• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经结膜25G玻璃体切割联合内界膜剥除术治疗慢性黄斑水肿

Transconjunctival 25-gauge pars plana vitrectomy and internal limiting membrane peeling for chronic macular edema.

作者信息

Cho Minhee, D'Amico Donald J

机构信息

Weill Cornell Medical College, Department of Ophthalmology, New York, NY, USA.

出版信息

Clin Ophthalmol. 2012;6:981-9. doi: 10.2147/OPTH.S33391. Epub 2012 Jul 6.

DOI:10.2147/OPTH.S33391
PMID:22848140
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3402127/
Abstract

BACKGROUND

The purpose of this study was to investigate the visual and anatomic outcomes in patients with chronic macular edema who underwent 25-gauge pars plana vitrectomy with internal limiting membrane peeling.

METHODS

This study was a retrospective chart review of 24 eyes from 21 patients who underwent 25-gauge pars plana vitrectomy and indocyanine green-assisted internal limiting membrane peeling for chronic macular edema. Preoperative and postoperative spectral-domain optical coherence tomography (OCT) was examined for macular thickness and macular volume. Outcomes and variables were analyzed using the two-tailed t-test and Spearman's rank correlation coefficient.

RESULTS

Twenty-four eyes from 11 men and 10 women of mean age 69 (range 55-84) years were included. Four patients (17%) had chronic macular edema from uveitis, four (17%) from retinal vein occlusion, and 16 (67%) from diabetes. Mean visual acuity was 20/103 preoperatively and 20/87 postoperatively (P = 0.55). Sixty-three percent of the eyes had improved vision (47% better than 20/40), 21% maintained the same vision, and 17% had worse vision. Forty-seven percent of improved eyes and 30% of total eyes gained more than two lines of visual acuity (range -9 to +7 lines). Mean macular thickness was 455 μm preoperatively and 396 μm postoperatively (P = 0.29). Mean macular volume was 7.9 mm(3) preoperatively and 7.5 mm(3) postoperatively (P = 0.51). The strongest predictor of postoperative visual acuity was initial visual acuity (r = 0.673, P = 0.0003).

CONCLUSION

Even though a majority of patients had improved vision and decreased macular thickening after 25-gauge pars plana vitrectomy with internal limiting membrane peeling for chronic macular edema of various etiologies, the difference in visual acuity or macular thickening did not reach statistical significance.

摘要

背景

本研究的目的是调查接受25G玻璃体切除术联合内界膜剥除术的慢性黄斑水肿患者的视力和解剖学结果。

方法

本研究是一项回顾性图表分析,纳入了21例接受25G玻璃体切除术联合吲哚菁绿辅助内界膜剥除术治疗慢性黄斑水肿的患者的24只眼。术前和术后使用光谱域光学相干断层扫描(OCT)检查黄斑厚度和黄斑体积。采用双尾t检验和Spearman等级相关系数分析结果和变量。

结果

纳入了11名男性和10名女性的24只眼,平均年龄69岁(范围55 - 84岁)。4例(17%)患者的慢性黄斑水肿由葡萄膜炎引起,4例(17%)由视网膜静脉阻塞引起,16例(67%)由糖尿病引起。术前平均视力为20/103,术后为20/87(P = 0.55)。63%的患眼视力改善(47%优于20/40),21%视力维持不变,17%视力下降。47%视力改善的患眼和30%的所有患眼视力提高超过两行(范围-9至+7行)。术前平均黄斑厚度为455μm,术后为396μm(P = 0.29)。术前平均黄斑体积为7.9mm³,术后为7.5mm³(P = 0.51)。术后视力的最强预测因素是初始视力(r = 0.673,P = 0.0003)。

结论

尽管大多数患者在接受25G玻璃体切除术联合内界膜剥除术治疗各种病因的慢性黄斑水肿后视力有所改善且黄斑增厚减轻,但视力或黄斑增厚的差异未达到统计学意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cfe/3402127/a048c0bc74c1/opth-6-981f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cfe/3402127/a048c0bc74c1/opth-6-981f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cfe/3402127/a048c0bc74c1/opth-6-981f1.jpg

相似文献

1
Transconjunctival 25-gauge pars plana vitrectomy and internal limiting membrane peeling for chronic macular edema.经结膜25G玻璃体切割联合内界膜剥除术治疗慢性黄斑水肿
Clin Ophthalmol. 2012;6:981-9. doi: 10.2147/OPTH.S33391. Epub 2012 Jul 6.
2
SURGICAL OUTCOMES IN PATIENTS WITH MACULAR PUCKER AND GOOD PREOPERATIVE VISUAL ACUITY AFTER VITRECTOMY WITH MEMBRANE PEELING.玻璃体切除联合膜剥除术后黄斑皱襞且术前视力良好患者的手术结果
Retina. 2015 Sep;35(9):1817-21. doi: 10.1097/IAE.0000000000000558.
3
Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Nontractional Diabetic Macular Edema.玻璃体后皮质切除术联合内界膜剥除术治疗非牵拉性糖尿病性黄斑水肿
Open Ophthalmol J. 2017 Jan 31;11:5-10. doi: 10.2174/1874364101711010005. eCollection 2017.
4
Optic nerve atrophy after vitrectomy with indocyanine green-assisted internal limiting membrane peeling in diffuse diabetic macular edema. Adverse effect of ICG-assisted ILM peeling.吲哚菁绿辅助内界膜剥除玻璃体切割术后弥漫性糖尿病性黄斑水肿的视神经萎缩。吲哚菁绿辅助内界膜剥除的不良影响。
Graefes Arch Clin Exp Ophthalmol. 2004 Dec;242(12):995-9. doi: 10.1007/s00417-004-0864-4. Epub 2004 Jul 17.
5
Pars plana vitrectomy and internal limiting membrane peeling for macular edema secondary to retinal vein occlusion.玻璃体切割术联合内界膜剥除术治疗视网膜静脉阻塞继发黄斑水肿
Clin Ophthalmol. 2011;5:1089-93. doi: 10.2147/OPTH.S23164. Epub 2011 Aug 5.
6
Visual outcome of patients with macular edema after pars plana vitrectomy and indocyanine green-assisted peeling of the internal limiting membrane.玻璃体切割联合吲哚菁绿辅助内界膜剥除术后黄斑水肿患者的视力预后
Graefes Arch Clin Exp Ophthalmol. 2004 Apr;242(4):273-8. doi: 10.1007/s00417-003-0731-8. Epub 2004 Mar 23.
7
Long-term effects of vitrectomy and internal limiting membrane peeling for macular edema secondary to central retinal vein occlusion and hemiretinal vein occlusion.玻璃体内切割术和内界膜剥除术治疗视网膜中央静脉阻塞和半侧视网膜静脉阻塞继发黄斑水肿的长期疗效。
Retina. 2010 Jan;30(1):117-24. doi: 10.1097/IAE.0b013e3181bced68.
8
Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid.对于无紧张后玻璃体后皮质的难治性糖尿病性黄斑水肿行玻璃体平坦部玻璃体切除术联合内界膜剥除术
Graefes Arch Clin Exp Ophthalmol. 2005 Jan;243(1):20-5. doi: 10.1007/s00417-004-0958-z. Epub 2004 Jul 31.
9
[Surgical Treatment of the Idiopathic Macular Hole by Means of 25-Gauge Pars Plana Vitrectomy with the Peeling of the Internal Limiting Membrane Assisted by Brilliant Blue and Gas Tamponade].[25G 经睫状体平坦部玻璃体切除术联合亮蓝辅助内界膜剥除及气体填充治疗特发性黄斑裂孔]
Cesk Slov Oftalmol. 2015 Jun;71(3):170-4.
10
LONG-TERM OUTCOMES OF 23-GAUGE PARS PLANA VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING AND GAS TAMPONADE FOR MYOPIC TRACTION MACULOPATHY: A Prospective Study.23G经睫状体平坦部玻璃体切除术联合内界膜剥除及气体填充治疗近视性牵引性黄斑病变的长期疗效:一项前瞻性研究
Retina. 2015 Sep;35(9):1836-43. doi: 10.1097/IAE.0000000000000554.

引用本文的文献

1
Long-Term Safety and Efficacy of Pars Plana Vitrectomy for Uveitis: Experience of a Tertiary Referral Centre in the United Kingdom.玻璃体切除术治疗葡萄膜炎的长期安全性和有效性:英国一家三级转诊中心的经验
J Clin Med. 2023 May 2;12(9):3252. doi: 10.3390/jcm12093252.
2
Insulin use and risk of diabetic macular edema in diabetes mellitus: a systemic review and meta-analysis of observational studies.糖尿病中胰岛素使用与糖尿病性黄斑水肿风险:观察性研究的系统评价和荟萃分析
Med Sci Monit. 2015 Mar 30;21:929-36. doi: 10.12659/MSM.892056.

本文引用的文献

1
Pars plana vitrectomy for diabetic macular edema. Internal limiting membrane delamination vs posterior hyaloid removal. A prospective randomized trial.经平坦部玻璃体切除术治疗糖尿病性黄斑水肿。内界膜剥离与后玻璃体膜切除的比较。一项前瞻性随机试验。
Graefes Arch Clin Exp Ophthalmol. 2011 Jul;249(7):997-1008. doi: 10.1007/s00417-010-1610-8. Epub 2011 Jan 18.
2
Preoperative inner segment/outer segment junction in spectral-domain optical coherence tomography as a prognostic factor in epiretinal membrane surgery.频域光学相干断层扫描术前内节/外节连接作为眼后膜手术的预后因素。
Retina. 2011 Jul-Aug;31(7):1366-72. doi: 10.1097/IAE.0b013e318203c156.
3
Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study.
糖尿病黄斑水肿中应用雷珠单抗的两年观察(READ-2)研究结果。
Ophthalmology. 2010 Nov;117(11):2146-51. doi: 10.1016/j.ophtha.2010.08.016. Epub 2010 Sep 19.
4
Visual acuity and foveal thickness after vitrectomy for macular edema associated with branch retinal vein occlusion: a case series.玻璃体切割术后伴分支视网膜静脉阻塞的黄斑水肿的视力和中心凹厚度:病例系列。
BMC Ophthalmol. 2010 Apr 29;10:11. doi: 10.1186/1471-2415-10-11.
5
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.随机、假手术对照试验研究地塞米松眼内植入剂治疗视网膜静脉阻塞所致黄斑水肿患者。
Ophthalmology. 2010 Jun;117(6):1134-1146.e3. doi: 10.1016/j.ophtha.2010.03.032. Epub 2010 Apr 24.
6
Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study.雷珠单抗治疗视网膜分支静脉阻塞继发黄斑水肿:一项 III 期研究的 6 个月主要终点结果。
Ophthalmology. 2010 Jun;117(6):1102-1112.e1. doi: 10.1016/j.ophtha.2010.02.021. Epub 2010 Apr 15.
7
Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study.雷珠单抗治疗视网膜中央静脉阻塞继发黄斑水肿:一项 III 期研究的 6 个月主要终点结果。
Ophthalmology. 2010 Jun;117(6):1124-1133.e1. doi: 10.1016/j.ophtha.2010.02.022. Epub 2010 Apr 9.
8
Long-term effects of vitrectomy and internal limiting membrane peeling for macular edema secondary to central retinal vein occlusion and hemiretinal vein occlusion.玻璃体内切割术和内界膜剥除术治疗视网膜中央静脉阻塞和半侧视网膜静脉阻塞继发黄斑水肿的长期疗效。
Retina. 2010 Jan;30(1):117-24. doi: 10.1097/IAE.0b013e3181bced68.
9
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6.一项比较玻璃体内注射曲安奈德与标准治疗方案治疗视网膜分支静脉阻塞继发黄斑水肿所致视力丧失的疗效和安全性的随机试验:视网膜静脉阻塞的标准治疗与皮质类固醇治疗(SCORE)研究报告6
Arch Ophthalmol. 2009 Sep;127(9):1115-28. doi: 10.1001/archophthalmol.2009.233.
10
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5.一项比较玻璃体内注射曲安奈德与观察治疗视网膜中央静脉阻塞继发黄斑水肿所致视力丧失的疗效和安全性的随机试验:视网膜静脉阻塞标准治疗与皮质类固醇治疗(SCORE)研究报告5
Arch Ophthalmol. 2009 Sep;127(9):1101-14. doi: 10.1001/archophthalmol.2009.234.